Pharma & Biotech - Page 5

Matt Turner, President of Patient Affordability at Paysign (PAYS), has introduced ClaimGuardRx, a proprietary large language model built to protect manufacturer affordability program value. The platform is designed to ensure that every

The pharmaceutical industry has largely solved the challenge of adopting artificial intelligence, but a harder problem is now taking centre stage: how to properly supervise it. Amy Brown, founder and CEO of

Takeda Pharmaceutical’s long-serving research and development chief Andy Plump is set to retire, marking the end of a significant era for the Japanese drugmaker. Plump has been a central figure in shaping

The FDA’s Oncology Center of Excellence has a firm hand at the helm as Angelo de Claro commits to driving forward the centre’s regulatory mission. De Claro currently serves as Director of

Paysign, Inc. (PAYS) has developed a purpose-built large language model at the core of its ClaimGuardRx platform, targeting fraud and diversion in patient affordability programmes. Bryan Dennison, Senior Vice President of Sales

Paysign’s Vice President of Patient Affordability, Logan Melchione, says clients are consistently frustrated by the dual burden of diversion and fraud on their programmes. Both problems drain copay assistance programmes of critical

HDA’s Kala Shankle is urging wholesale distributors and third-party logistics providers not to wait for Washington before preparing for national licensure requirements. Shankle’s core message is that the work required ahead of

DHL Group is significantly expanding its Life Sciences and Healthcare capabilities in Singapore through a series of major infrastructure investments targeting the Asia Pacific market. The expansion builds on the earlier opening

Caris Life Sciences (NASDAQ: CAI) has launched a national advertising campaign called “Math,” starring award-winning actor, producer and director Kevin Costner. The campaign is designed to raise public awareness about the importance